跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
FLEBOGAMMA 10% DIF normal immunoglobulin (Human) intravenous use injection vial - TGA Drug Approval Details
Approvals
/
TGA
/
FLEBOGAMMA 10% DIF normal immunoglobulin (Human) intravenous use injection vial
Approved
STANDARD
FLEBOGAMMA 10% DIF normal immunoglobulin (Human) intravenous use injection vial
Grifols Australia Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 30, 2025
Approval ID
922feafc6de3ae6a
Company
Grifols Australia Pty Ltd
Type
Standard
Approval Details
Approval Id
922feafc6de3ae6a
Product Name
FLEBOGAMMA 10% DIF normal immunoglobulin (Human) intravenous use injection vial
Artg Id
184353
Artg Name
FLEBOGAMMA 10% DIF normal immunoglobulin (Human) 5g/50mL intravenous use injection vial
Sponsor
Grifols Australia Pty Ltd
Company Detail Path
/organization/grifols-australia-pty-ltd
Artg Date
2013-02-12
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Consumer Medicine Info
https://medical-cdn.nocode.com/drug_tga/fe3e6e33318f29dfc60815077a8c4cdf.pdf
Product Information
https://medical-cdn.nocode.com/drug_tga/40ac0ec20e3726e271df6d9dde6bd654.pdf
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 30, 2025
Approval ID
922feafc6de3ae6a
Type
Standard
Back to TGA Approvals